EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies

Annapaola Montagner, Andrea Arleo iD, Fabrizia Suzzi iD, Antonino B D'Assoro, Fabio Piscaglia iD, Laura Gramantieri iD, Catia Giovannini iD

Biomolecules · 11.12.2024 · 14 (12) · 1581

DOI: 10.3390/biom14121581 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 11.12.2024. Verfasst von Annapaola Montagner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Bologna University, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Signal Transduction, Receptors, Notch. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Emilia-Romagna, University of Bologna, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has shown significant improvement in the survival of patients with hepatocellular carcinoma (HCC) compared to TKIs as first-line treatment. Unfortunately, approximately 30% of HCC exhibits intrinsic resistance to ICIs, making new therapeutic combinations urgently needed. The dysregulation of the Notch signaling pathway observed in HCC can affect immune cell response, reducing the efficacy of cancer immunotherapy. Here, we provide an overview of how Notch signaling regulates immune responses and present the therapeutic rationale for combining Notch signaling inhibition with ICIs to improve HCC treatment. Moreover, we propose using exosomes as non-invasive tools to assess Notch signaling activation in hepatic cancer cells, enabling accurate stratification of patients who can benefit from combined strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsSignal TransductionReceptors, NotchProgrammed Cell Death 1 ReceptorB7-H1 AntigenHumansImmunotherapyImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

NotchPD-1PD-L1combination therapyhepatocellular carcinoma (HCC)immunotherapy

Substanzen

Receptors, NotchProgrammed Cell Death 1 ReceptorB7-H1 AntigenPDCD1 protein, humanCD274 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Bologna University, 40138 Bologna, Italy.
  • Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN 55902, USA.
  • Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

ORCID-Profile: Andrea Arleo, Fabrizia Suzzi, Fabio Piscaglia, Laura Gramantieri, Catia Giovannini

Förderung

  • Regione Emilia-Romagna
  • University of Bologna
  • Ministero della Salute
  • Italian Ministry of Health
  • BIBLIOSAN

Zitieren

APA

Montagner, A., Arleo, A., Suzzi, F., D'Assoro, A. B., Piscaglia, F., Gramantieri, L., & Giovannini, C. (2024). Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies. Biomolecules, 14(12), 1581. https://doi.org/10.3390/biom14121581

Vancouver

Montagner A, Arleo A, Suzzi F, D'Assoro AB, Piscaglia F, Gramantieri L, et al. Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies. Biomolecules. 2024;14(12):1581. doi:10.3390/biom14121581

BibTeX
@article{Montagner2024,
  author = {Montagner, Annapaola and Arleo, Andrea and Suzzi, Fabrizia and D'Assoro, Antonino B and Piscaglia, Fabio and Gramantieri, Laura and Giovannini, Catia},
  title = {Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {1581},
  doi = {10.3390/biom14121581}
}
Kostenlos starten →